Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Total Valuation
Globus Medical has a market cap or net worth of $11.45B. The enterprise value is $11.06B.
Market Cap$11.45B
Enterprise Value$11.06B
Share Statistics
Globus Medical has 112,625,130 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding112,625,130
Owned by Insiders0.72%
Owned by Institutions25.20%
Financial Efficiency
Globus Medical’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.78%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)8.78%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee554.51K
Profits Per Employee101.48K
Employee Count5,300
Asset Turnover0.55
Inventory Turnover1.26
Valuation Ratios
The current PE Ratio of Globus Medical is 21.9. Globus Medical’s PEG ratio is 0.05.
PE Ratio21.9
PS Ratio4.02
PB Ratio2.58
Price to Fair Value2.58
Price to FCF20.04
Price to Operating Cash Flow15.21
PEG Ratio0.05
Income Statement
In the last 12 months, Globus Medical had revenue of 2.94B and earned 537.90M in profits. Earnings per share was 3.98.
Revenue2.94B
Gross Profit1.98B
Operating Income479.80M
Pretax Income609.90M
Net Income537.90M
EBITDA729.90M
Earnings Per Share (EPS)3.98
Cash Flow
In the last 12 months, operating cash flow was 753.45M and capital expenditures -174.68M, giving a free cash flow of 578.77M billion.
Operating Cash Flow753.45M
Free Cash Flow578.77M
Free Cash Flow per Share5.14
Dividends & Yields
Globus Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.83
52-Week Price Change17.51%
50-Day Moving Average90.57
200-Day Moving Average71.72
Relative Strength Index (RSI)36.22
Average Volume (3m)1.68M
Important Dates
Globus Medical upcoming earnings date is May 12, 2026, After Close (Confirmed).
Last Earnings DateFeb 24, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
Globus Medical as a current ratio of 4.26, with Debt / Equity ratio of 2.59%
Current Ratio4.26
Quick Ratio2.74
Debt to Market Cap0.01
Net Debt to EBITDA-0.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Globus Medical has paid 72.00M in taxes.
Income Tax72.00M
Effective Tax Rate0.12
Enterprise Valuation
Globus Medical EV to EBITDA ratio is 15.61, with an EV/FCF ratio of 19.35.
EV to Sales3.88
EV to EBITDA15.61
EV to Free Cash Flow19.35
EV to Operating Cash Flow15.12
Balance Sheet
Globus Medical has $557.24M in cash and marketable securities with $118.66M in debt, giving a net cash position of $438.59M billion.
Cash & Marketable Securities$557.24M
Total Debt$118.66M
Net Cash$438.59M
Net Cash Per Share$3.89
Tangible Book Value Per Share$17.71
Margins
Gross margin is 67.41%, with operating margin of 16.33%, and net profit margin of 18.30%.
Gross Margin67.41%
Operating Margin16.33%
Pretax Margin20.75%
Net Profit Margin18.30%
EBITDA Margin24.84%
EBIT Margin20.75%
Analyst Forecast
The average price target for Globus Medical is $108.54, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$108.54
Price Target Upside28.04% Upside
Analyst ConsensusStrong Buy
Analyst Count14
Revenue Growth Forecast11.75%
EPS Growth Forecast364.73%